234 related articles for article (PubMed ID: 15949537)
1. Prostanoids and phosphodiesterase inhibitors in experimental pulmonary hypertension.
Theo Schermuly R; Ardeschir Ghofrani H; Weissmann N
Curr Top Dev Biol; 2005; 67():251-84. PubMed ID: 15949537
[TBL] [Abstract][Full Text] [Related]
2. [Update: Current clinical developments in pulmonary hypertension].
Dumitrescu D; Ghofrani HA; Grimminger F; Hoeper MM; Rosenkranz S
Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S160-3. PubMed ID: 19718605
[TBL] [Abstract][Full Text] [Related]
3. Management of dyspnea in advanced pulmonary arterial hypertension.
Sajkov D; Petrovsky N; Palange P
Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension.
Ghofrani HA; Pepke-Zaba J; Barbera JA; Channick R; Keogh AM; Gomez-Sanchez MA; Kneussl M; Grimminger F
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):68S-72S. PubMed ID: 15194181
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological treatment of pulmonary hypertension in patients with congenital heart disease].
Miera O; Farahwaschy B; Schulze-Neick I; Berger F
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S209-11. PubMed ID: 18814099
[TBL] [Abstract][Full Text] [Related]
6. Current treatment strategies for pulmonary arterial hypertension.
Lee SH; Rubin LJ
J Intern Med; 2005 Sep; 258(3):199-215. PubMed ID: 16115293
[TBL] [Abstract][Full Text] [Related]
7. Current therapies for pulmonary arterial hypertension.
Takaoka S; Faul JL; Doyle R
Semin Cardiothorac Vasc Anesth; 2007 Jun; 11(2):137-48. PubMed ID: 17536117
[TBL] [Abstract][Full Text] [Related]
8. [Prostanoids in the treatment of pulmonary arterial hypertension].
Başkurt M; Küçükoğlu MS
Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():2-8. PubMed ID: 20819749
[TBL] [Abstract][Full Text] [Related]
9. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.
Ravipati G; McClung JA; Aronow WS; Peterson SJ; Frishman WH
Cardiol Rev; 2007; 15(2):76-86. PubMed ID: 17303994
[TBL] [Abstract][Full Text] [Related]
10. Practical considerations for the pharmacotherapy of pulmonary arterial hypertension.
Bishop BM; Mauro VF; Khouri SJ
Pharmacotherapy; 2012 Sep; 32(9):838-55. PubMed ID: 22806762
[TBL] [Abstract][Full Text] [Related]
11. Role of combination therapy in the treatment of pulmonary arterial hypertension.
Abraham T; Wu G; Vastey F; Rapp J; Saad N; Balmir E
Pharmacotherapy; 2010 Apr; 30(4):390-404. PubMed ID: 20334459
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs.
Safdar Z
Respir Med; 2011 Jun; 105(6):818-27. PubMed ID: 21273054
[TBL] [Abstract][Full Text] [Related]
13. Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies.
van Loon RL; Roofthooft MT; Delhaas T; van Osch-Gevers M; ten Harkel AD; Strengers JL; Backx A; Hillege HL; Berger RM
Am J Cardiol; 2010 Jul; 106(1):117-24. PubMed ID: 20609658
[TBL] [Abstract][Full Text] [Related]
14. [Dana Point: what is new in the treatment of pulmonary hypertension?].
Hoeper MM; Ghofrani HA; Grimminger F; Rosenkranz S
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S191-5. PubMed ID: 18814094
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapies in pulmonary arterial hypertension.
Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
[TBL] [Abstract][Full Text] [Related]
16. Sarcoidosis-associated pulmonary hypertension: assessment and management.
Palmero V; Sulica R
Semin Respir Crit Care Med; 2010 Aug; 31(4):494-500. PubMed ID: 20665399
[TBL] [Abstract][Full Text] [Related]
17. Emerging drugs for pulmonary hypertension.
Girgis RE
Expert Opin Emerg Drugs; 2010 Mar; 15(1):71-85. PubMed ID: 20095920
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary arterial hypertension. Part II: Medical and surgical treatment].
Manes A; Marinelli A; Palazzini M; Negro L; Leci E; Gambetti S; Bachetti C; Beciani E; Conficoni E; Branzi A; Galiè N
G Ital Cardiol (Rome); 2009 Jun; 10(6):366-81. PubMed ID: 19603608
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin and its analogues in the treatment of pulmonary hypertension.
Olschewski H; Rose F; Schermuly R; Ghofrani HA; Enke B; Olschewski A; Seeger W
Pharmacol Ther; 2004 May; 102(2):139-53. PubMed ID: 15163595
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary hypertension and pulmonary circulation in congenital heart disease].
Schulze-Neick I; Kaemmerer H
Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S170-2. PubMed ID: 19718608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
